Utama › Adenokarsinoma Esofagus
Kajian klinikal Adenokarsinoma Esofagus sedang mengambil peserta di AS
47 kajian untuk Adenokarsinoma Esofagus sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- New York City, NY18 kajian
- Boston, MA13 kajian
- Houston, TX12 kajian
- Nashville, TN11 kajian
- Arlington, VA11 kajian
- Durham, NC10 kajian
- Los Angeles, CA9 kajian
- St. Louis, MO9 kajian
- Queens, NY9 kajian
- Baldwin Park, CA9 kajian
- Rochester, MN9 kajian
- Jacksonville, FL9 kajian
- Chicago, IL8 kajian
- Pittsburgh, PA8 kajian
- Philadelphia, PA8 kajian
- Dallas, TX8 kajian
- Orange, CA7 kajian
- Seattle, WA7 kajian
- Ann Arbor, MI7 kajian
- Evanston, IL6 kajian
- Indianapolis, IN6 kajian
- Washington, DC6 kajian
- Minneapolis, MN6 kajian
- Portland, OR6 kajian
- Aurora, CO6 kajian
- Cleveland, OH6 kajian
- New Haven, CT5 kajian
- Sioux Falls, SD5 kajian
- Greenburgh, NY5 kajian
- Kansas City, MO5 kajian
- Rochester, NY5 kajian
- Charleston, SC5 kajian
- San Antonio, TX5 kajian
- Denver, CO5 kajian
- Tampa, FL4 kajian
- Cedar Rapids, IA4 kajian
- Salt Lake City, UT4 kajian
- Waukegan, IL4 kajian
- Bridgeport, CT4 kajian
- San Francisco, CA4 kajian
Mengikut negeri
- Alaska3 kajian
- Arizona10 kajian
- Arkansas4 kajian
- California22 kajian
- Colorado11 kajian
- Connecticut7 kajian
- Delaware3 kajian
- Florida15 kajian
- Georgia5 kajian
- Illinois11 kajian
- Indiana6 kajian
- Iowa5 kajian
- Kansas5 kajian
- Louisiana3 kajian
- Maryland6 kajian
- Massachusetts13 kajian
- Michigan9 kajian
- Minnesota14 kajian
- Missouri11 kajian
- Nebraska4 kajian
- Nevada5 kajian
- New Jersey9 kajian
- New York20 kajian
- North Carolina12 kajian
- Ohio12 kajian
- Oklahoma4 kajian
- Oregon6 kajian
- Pennsylvania15 kajian
- South Carolina6 kajian
- South Dakota5 kajian
- Tennessee13 kajian
- Texas19 kajian
- Utah5 kajian
- Virginia13 kajian
- Washington9 kajian
- Wilayah Columbia4 kajian
- Wisconsin7 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06203600mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05677490A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07090499Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06324357A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07221149Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07603375Lucid Registry Study
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 28 Sep 2026 · NCT05965999Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07392892A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07277413Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06005493Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07546812Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 50 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06687603A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07818018Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT06732388Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
Mengambil peserta
Umur 18 hingga 89 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT05753748A Study of KK2269 in Adult Participants With Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT06266299Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07431281Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 8 Sep 2026 · NCT07282912A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT07544589Liquid Nitrogen Spray Cryotherapy Prior to Neoadjuvant Systemic Therapy in Esophageal Adenocarcinoma
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT07222657A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT07182149Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Ogo 2026 · NCT04221893Obeticholic Acid for Prevention in Barrett's Esophagus
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT04939051A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Ogo 2026 · NCT06330064A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Jul 2026 · NCT06657144Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.